Phase II Study of The Combination of Liposomal Irinotecan and Pembrolizumab For Triple-Negative Breast Cancer (TNBC) With Brain Metastases (BM)

Status: Open to Accrual

Learn more:

• clinicaltrials.gov: #NCT05255666

Study Contact: studies@hoosiercancer.org; (317) 921-2050.